Honeywell International Inc. reduced its position in shares of Aetna Inc. (NYSE:AET) by 11.6% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 152,512 shares of the company’s stock after selling 20,000 shares during the period. Honeywell International Inc.’s holdings in Aetna were worth $23,156,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America boosted its position in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares in the last quarter. Concert Wealth Management Inc. boosted its position in Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares in the last quarter. CAPROCK Group Inc. boosted its position in Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares in the last quarter. Rehmann Capital Advisory Group boosted its position in Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock worth $298,000 after buying an additional 25 shares in the last quarter. Finally, Geneva Advisors LLC boosted its position in Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock worth $330,000 after buying an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 91.73% of the company’s stock.

Aetna Inc. (NYSE:AET) opened at 155.58 on Thursday. The company has a 50-day moving average price of $154.27 and a 200 day moving average price of $138.69. Aetna Inc. has a 12-month low of $104.59 and a 12-month high of $161.69. The stock has a market cap of $51.61 billion, a price-to-earnings ratio of 47.45 and a beta of 0.54.

Aetna (NYSE:AET) last posted its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The business had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.21 EPS. On average, equities research analysts predict that Aetna Inc. will post $9.43 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, July 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.29%. Aetna’s payout ratio is 43.67%.

ILLEGAL ACTIVITY WARNING: This story was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/08/10/aetna-inc-nyseaet-position-reduced-by-honeywell-international-inc.html.

A number of research analysts recently commented on the company. UBS AG reiterated a “buy” rating and issued a $160.00 price objective (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Argus reissued a “buy” rating and issued a $165.00 target price (up previously from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a research report on Wednesday. Credit Suisse Group reissued a “buy” rating and issued a $155.00 target price on shares of Aetna in a research report on Wednesday, May 17th. Finally, Cleveland Research raised Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Eight investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Aetna has an average rating of “Buy” and an average target price of $157.09.

In related news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of Aetna stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the transaction, the chairman now owns 659,888 shares in the company, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.